Veracyte 10K 2016 Annual report | VCYT Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: ACCE, ADLT, affirmative, analyst, Arlington, array, Australia, bore, Burn, capability, Castle, CDPH, CGS, China, clarity, classic, compliant, Concurrent, Cooperation, decipher, dialogue, die, distinction, domiciled, embrace, ENDO, Envisia, envision, EU, feedback, flagship, fourteen, frail, fueling, fundamentally, GE, Gordon, grandfather, grandfathered, histopathology, imagination, immaterial, interact, iv, juncture, Keith, Kennedy, Kevin, Kislak, Korea, LCD, LP, main, manuscript, Mary, match, MCG, modality, MolDx, nasal, notoriously, NYSDOH, paper, Pennant, piece, pledge, preferential, principle, profile, ready, reconciling, reconsideration, redefining, repaid, repeal, reside, Rx, shareholder, simple, spark, spectrum, stabilize, strive, supersede, swab, teach, thirteen, transformation, transforming, transparent, transpose, Treasurer, Treaty, trustworthy, undergone, unusable, unused, vast, version, vision, Visium

Removed: ablation, accelerate, accessible, accession, accessioning, adjunctive, adult, advocacy, advocating, aggressive, agnostic, airway, alfa, alter, analytically, applying, assay, attended, atypia, authorized, automated, banking, biology, biopharmaceutical, blinded, book, breast, broadly, byThyroid, call, capture, Carlo, cell, cellularity, centerpiece, centimeter, cervix, challenging, choice, CI, Cigna, cited, closed, cohort, Commissioner, community, compelling, comprising, confirmed, conservative, contrast, correctly, country, cytological, cytologically, database, degradation, derivative, destruction, detailed, deviation, DHS, diameter, differentiated, discretionary, disposition, distill, diversity, dividend, doctor, document, domestically, double, drawn, driven, ear, efficiently, EGAPP, endocrinologist, endocrinology, endometrium, ensuring, ENT, eventual, exhibited, extinguished, Extracting, fastest, fewer, FNAProtect, follicular, foundational, freestanding, freezer, gold, Guyer, headquartered, historic, hormone, Humana, increasingly, informed, injection, interval, inThe, inThyroid, investor, iRhythm, left, lender, lesion, lt, Markov, maximize, medullary, Metabolism, minimally, mixed, modeled, modest, Monte, Morgan, mRNA, mutation, navigate, NCCN, negligible, nose, Nuvelo, obscured, observation, observed, opted, optimal, overnight, parallel, pathologic, permitting, pivotal, planning, PositionBonnie, predecessor, predictable, preoperatively, preserved, preventive, Princeton, producing, progression, progressive, promise, proposition, prove, qualification, qualifying, reagent, reclassify, region, Reitpath, relation, reproducible, repurchase, respiratory, revalued, reverse, room, routine, run, save, scarring, seasonality, selecting, sending, shape, Shelly, simulation, sized, specialty, sponsor, sponsored, stable, stage, stained, steering, stored, structure, suboptimal, substantive, succeeded, summer, surgeon, sustained, Switzerland, tactical, Task, temperature, theJournal, therapy, throat, Thyrogen, thyrotropin, today, tolerance, ultrasonographically, underwent, undiscounted, universally, untreated, upheaval, UpToDate, utilized, valid, validating, Valley, variability, variation, vertical, visit, waiting, watchful, weather, widely, winter, workflow, worldwide, yield



Date:	March 1, 2017

		/s/ Keith S. Kennedy
		Keith S. Kennedy
		Chief Financial Officer
		(Principal Financial and Accounting Officer)


(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Veracyte (VCYT) 10-K2016 FY Annual report

Content analysis